Core Viewpoint - The introduction of the "Guangxi Marine Traditional Chinese Medicine Standard" marks a significant step towards the standardization and industrialization of marine medicinal materials in China, addressing the lack of unified quality standards in the sector [1][2]. Group 1: Standard Implementation - The newly established standard includes 37 marine medicinal species, detailing quality indicators, inspection methods, and therapeutic functions, filling a gap in China's marine medicinal material standardization system [1][2]. - The standard was developed through multiple rounds of research and expert validation, aligning with the current "Chinese Pharmacopoeia" requirements [2]. Group 2: Economic Impact - In 2024, the added value of Guangxi's emerging marine industries is expected to grow by 45%, with marine pharmaceuticals and biological products becoming key growth drivers for the coastal economy [2]. - The standard is anticipated to inject strong momentum into the development of Guangxi's marine biomedicine industry, facilitating the transition from resource advantages to industrial and economic advantages [2]. Group 3: Resource and Market Development - Standardization will regulate the harvesting and processing of marine medicinal materials, promoting sustainable utilization of the "blue pharmacy" in the Beibu Gulf [2]. - Clear quality standards will reduce R&D and production costs for enterprises, guiding the industry chain towards high value-added sectors and upgrading the entire supply chain from raw materials to health product production [2]. - Unified standards will enhance the credibility and competitiveness of Guangxi's marine medicinal materials, aiding the "Gui brand" in reaching national and international markets [2].

Core Viewpoint - The implementation of the "Guangxi Marine Traditional Chinese Medicine Standard" marks a significant step towards the standardization and industrialization of marine medicinal materials in China, addressing the lack of unified quality standards in the sector [1][2] Group 1: Standard Implementation - The newly established provincial standard includes 37 marine medicinal material varieties, specifying quality indicators, inspection methods, and therapeutic functions [1] - This standard fills a gap in China's marine medicinal material standardization system, indicating a new phase for the development of the "blue pharmacy" in the Beibu Gulf [1] Group 2: Industry Development - Guangxi's coastal line and rich marine biological resources have led to the identification of over 700 marine species with medicinal value, including traditional uses of species like sandworms and oysters [1] - The marine pharmaceutical and biological products industry in Guangxi is projected to see a 45% year-on-year increase in added value in 2024, becoming a key growth point for the marine economy [2] - The release of the standard is expected to inject strong momentum into the development of Guangxi's marine biomedicine industry, facilitating the transformation from resource advantages to economic advantages [2]